D'Haenen H
Service de Psychiatrie, Chargé de cours à l'Université, A.Z.-V.U.B.
Acta Psychiatr Belg. 1995;95(6):332-6.
Two subjects are discussed: the use of placebo controls in clinical trials and informed consent. Particularly in trials of drugs for disorders for which there exist effective treatments, the use of placebo is still controversial, although anyhow in violation of the Declaration of Helsinki. Informed consent aims at giving a subject all the necessary information to allow him to decide, with full knowledge, whether to accept a particular treatment or experimental protocol. Its importance would seem, albeit essential, to be rather illusory.
临床试验中安慰剂对照的使用和知情同意。特别是在针对已有有效治疗方法的疾病的药物试验中，安慰剂的使用仍然存在争议，尽管无论如何这都违反了《赫尔辛基宣言》。知情同意旨在向受试者提供所有必要信息，使其能够在充分了解的情况下决定是否接受特定治疗或实验方案。其重要性虽然至关重要，但似乎相当虚幻。
